Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

First diabetes prevalence study in Portugal: PREVADIAB study

Gardete‐Correia, L., Boavida, J. M., Raposo, J. F., Mesquita, A. C., Fona, C., Carvalho, R., Massano‐Cardoso, S.·2010·Diabetic Medicine

Abstract

Diabet. Med. 27, 879–881 (2010) Aims Diabetes is a growing worldwide problem. Ascertaining its prevalence is vital as a starting point to establish and measure the success of health interventions. This study aimed to determine the prevalence of Type 2 diabetes and ‘pre‐diabetes’, defined as impaired fasting glucose and impaired glucose tolerance, in the Portuguese population aged between 20 and 79 years. Methods Considering the number of inhabitants between 20 and 79 years old, statistical units were selected that were representative regionally and nationally. The total sample comprised 5167 subjects. National prevalence was calculated. Analyses were performed on all those without previously known diabetes using World Health Organization reference diagnostic criteria. Results We found a diabetes prevalence of 11.7% (95% confidence interval 10.8–12.6%), with a significant difference between men (14.2%; 95% confidence interval 12.5–15.5%) and women (9.5%; 95% confidence interval 8.5–10.6%). While 6.6% of the subjects had previously been diagnosed with diabetes, 5.1% were undiagnosed. By age groups, 2.4% of the population between 20 and 39 years, 12.6% of people from 40 to 59 years old and 26.3% of those aged between 60 and 79 years had diabetes. Prevalence of ‘pre‐diabetes’ (impaired fasting glucose, impaired glucose tolerance or both) in the population was 23.3%. Conclusions Diabetes has a high prevalence in Portugal. If ‘pre‐diabetes’ is also considered, about one‐third (34.9%) of the population aged 20–79 years is affected. A greater number of males were found to have diabetes. We detected a high percentage of people with undiagnosed diabetes (43.6%).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.03017.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 260

Metadata

Authors
Gardete‐Correia, L., Boavida, J. M., Raposo, J. F., Mesquita, A. C., Fona, C., Carvalho, R., & Massano‐Cardoso, S.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-07-15
Volume
27
Issue
8
Pages
879-881
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1843908007
Cited by
260
References
1
FWCI
31.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: First diabetes prevalence study in Portugal: PREVADIAB study. https://app.cochat.ai/papers/10.1111/j.1464-5491.2010.03017.x
The paper
Gardete‐Correia, L., Boavida, J. M., Raposo, J. F., Mesquita, A. C., Fona, C., Carvalho, R., & Massano‐Cardoso, S. (2010). First diabetes prevalence study in Portugal: PREVADIAB study. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2010.03017.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.